Suppr超能文献

心肌细胞程序性坏死:线粒体、死亡受体及其他。

Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond.

机构信息

State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Peking University, Beijing, China.

出版信息

Br J Pharmacol. 2019 Nov;176(22):4319-4339. doi: 10.1111/bph.14363. Epub 2018 Jun 25.

Abstract

Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell death, whereas necrosis has been regarded to be an unregulated process. Recent findings reveal that necrosis also occurs in a regulated manner and that it is closely related to the physiology and pathophysiology of many organs, including the heart. The recognition of necrosis as a regulated process mandates a re-examination of cell death in the heart together with the mechanisms and therapy of cardiac diseases. In this study, we summarize the regulatory mechanisms of the programmed necrosis of cardiomyocytes, that is, the intrinsic (mitochondrial) and extrinsic (death receptor) pathways. Furthermore, the role of this programmed necrosis in various heart diseases is also delineated. Finally, we describe the currently known pharmacological inhibitors of several of the key regulatory molecules of regulated cell necrosis and the opportunities for their therapeutic use in cardiac disease. We intend to systemically summarize the recent progresses in the regulation and pathological significance of programmed cardiomyocyte necrosis along with its potential therapeutic applications to cardiac diseases. LINKED ARTICLES: This article is part of a themed section on Mitochondrial Pharmacology: Featured Mechanisms and Approaches for Therapy Translation. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc.

摘要

心肌细胞的过度死亡会导致许多心脏疾病,包括心肌梗死、心律失常、心力衰竭和心脏性猝死。在过去的几十年中,大多数关于细胞死亡的研究都集中在细胞凋亡上,细胞凋亡通常被认为是唯一形式的受调控的细胞死亡,而坏死则被认为是一种不受调控的过程。最近的发现揭示了坏死也以受调控的方式发生,并且与包括心脏在内的许多器官的生理学和病理生理学密切相关。坏死被认为是一种受调控的过程,这就要求重新审视心脏中的细胞死亡以及心脏疾病的机制和治疗方法。在本研究中,我们总结了心肌细胞程序性坏死的调节机制,即内在(线粒体)和外在(死亡受体)途径。此外,还描述了这种程序性坏死在各种心脏疾病中的作用。最后,我们描述了几种调控细胞坏死的关键调节分子的已知药理学抑制剂及其在心脏疾病治疗中的应用机会。我们旨在系统地总结程序性心肌细胞坏死的调节和病理意义以及其在心脏疾病治疗中的潜在应用的最新进展。

相关文章

本文是关于线粒体药理学的专题部分的一部分:特色机制和治疗转化方法。要查看本部分中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb62/6887687/08da7990a591/BPH-176-4319-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验